Prematurity is the major risk factor for late-onset group B streptococcus disease.
about
Group B Streptococcus vaccine: state of the artA maternal vaccine against group B Streptococcus: past, present, and futureGroup B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesUnderstanding the regulation of Group B Streptococcal virulence factorsPrevention of neonatal group B streptococcus disease in the 21st centuryClinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.Neonatal group B streptococcal disease: incidence, presentation, and mortality.Synchronous recurrence of group B streptococcal late-onset sepsis in twinsLate-onset bloodstream infections in hospitalized term infants.Neonatal group B streptococcal infection at the University Hospital of the West Indies, Jamaica: a 10-year experience.Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.Recurrent sepsis and neuroinvasive disease in a neonate culture-positive for a Group B Streptococcus CPS III serotype, hvgA+ strain.An update on vaccination against group B streptococcus.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.Preventing newborn infection with maternal immunization.To feed or not to feed? Case presentation and best practice guidance for human milk feeding and group B streptococcus in developed countries.The impact of group B streptococcus prophylaxis on late-onset neonatal infections.Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis.Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.Late Onset Streptococcus agalactiae Meningitis following Early Onset Septicemia: A Preventable Disease?Maternal recto vaginal colonization in term and preterm deliveries.Implication of Soluble Forms of Cell Adhesion Molecules in Infectious Disease and Tumor: Insights from Transgenic Animal Models.Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Risk factors for neonatal early-onset group B streptococcus-related diseases after the implementation of a universal screening program in Taiwan.Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population.Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets
P2860
Q26796438-FCBF6551-3ECD-4A40-82D0-26B839ED8DF4Q26822039-32A0F4EF-F355-4971-8018-AC79DCD9DDF4Q28075884-BA7110AE-6CCF-4536-9D7A-2690BC413732Q28237019-DBC93F92-2984-4CAE-B793-CA71CA91B79EQ29399413-04323CAF-CE88-4FA5-B170-5B867F183ED8Q30433993-51C6AD5B-8C73-4C08-9620-13419E9A2666Q33378153-22556B65-E660-40F0-B78E-F4134613C69DQ33551721-19AB2981-D6DA-4DCF-AEF2-93EBCB6DCB9AQ34161144-A11653B7-916F-487A-B951-444DE4A43028Q36403773-9FCB83CF-6464-46AC-8F66-C8A62910DEADQ37174864-258D7F9D-4395-4579-BA6D-C5D9AC315066Q37671554-9261A41F-FFA2-495F-9F26-D1F7DB7A7DBEQ37878487-E2CA60D9-7803-4FF0-A0E3-DE4478DB60C0Q38570903-AFE1AF1D-DF9F-4C9B-94E9-2256E8BD2F7FQ39386700-B747EFBF-1A8B-4AED-94FE-29D93B925896Q40091166-A7753C25-77AE-4792-813E-61A050B68E19Q40513651-BD2B98BC-3866-4655-B9C9-7C115E3F2D82Q41186429-86BC7E6E-6119-45E9-9DB9-53F1A07215D4Q42253830-24C03064-1436-45CD-919F-1AA19F7A050FQ42270473-4C2FA93B-6334-41D5-B8D6-7693A790538DQ43870067-564325AB-DCEA-4D87-8CBF-A02821876AD4Q45397507-A515801A-8949-49FD-B56D-6351C1C4DA3DQ46543437-71442E38-CE69-458B-A5F7-B84ED83E8767Q47134871-C704C1E3-3EE0-47BA-93FA-B9DF55FD6853Q47136396-00E786A8-3EE3-4651-A7A7-5A8BF281FBE8Q47552397-1B2EE6EC-8102-4C8A-A611-E0493E0F2B0EQ47586339-7E808C8E-A7A0-4B9A-A92D-0F3E28166600Q54243372-2467FD60-DBDC-4A0A-A4BE-3A5F6C885E2CQ55011294-13700F38-0AA9-4A37-92BF-05AAD52DFB73Q57169196-F717B19D-0907-4E9B-8F64-2398223A2045
P2860
Prematurity is the major risk factor for late-onset group B streptococcus disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@en
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@nl
type
label
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@en
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@nl
prefLabel
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@en
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@nl
P2093
P356
P1476
Prematurity is the major risk factor for late-onset group B streptococcus disease.
@en
P2093
Feng-Ying C Lin
James Troendle
Karen Adams
Leonard E Weisman
P304
P356
10.1086/376457
P407
P577
2003-07-01T00:00:00Z